AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $24.64M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.00pm 04/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
| Daily Volume | 0 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 5.3¢ | 100000 | 0 | 7.5¢ | 322778 | |
Directors & Senior Management
| Mr. Bob Lee | Chief Operating Officer |
| Prof. Christiani Jeyakumar Henry | Member of the Scientific Advisory Board |
| Mr. Daniel Joseph O'Connor | Non-Executive Director |
| Mr. Gregory P. Pilant | Non-Independent Non-Executive Director |
| Mr. James Richard Stephenson | CFO & Company Secretary |
| Mr. Kwok Kin Lai | Independent Non-Executive Chairman |
| Mr. Leong Man Loong | CEO & Executive Director |
| Dato' Dr. M. Rajendran Marnickavasagar | Interim Chairman of the Board |
| Mr. Robert Gemelli | Independent Non-Executive Director |
| Dr. Roscoe M. Moore | Head of the Scientific Advisory Board |
| Mr. Yuen Keong Yee | Independent Non-Executive Director |
Data source: ADVFN
